Ex parte DICK et al. - Page 15




              Appeal No. 1995-2297                                                                                           
              Application No. 07/797,493                                                                                     



              hematopoietic progenitor cells, particularly of the myeloid, lymphoid, and erythroid                           
              lineages.”                                                                                                     
                      In view of this disclosure, the scope of appellants’ claims 13 and 14 is unclear.  The                 
              claims are drawn to “[a] chimeric mouse having a stable bone marrow graft of lineage-                          
              specific human hematopoietic cells . . . .”  Appellants’ Examples 5 and 6 demonstrate that                     
              the bone marrow graft includes “multiple lineages of myeloid, lymphoid and erythroid cells,”                   
              and that administration of a lineage specific growth factor supports the differentiation of                    
              engrafted precursor cells into mature cells.  Nothing in the claim requires the presence of                    
              “mature” cells, thus the lineage-specific human hematopoietic cells claimed can include                        
              precursor cells.  However, it appears that appellants intend the lineage specific cells to be                  
              “mature cells”, see, e.g., Brief, page 10, “only macrophage progenitors were found; no                         
              mature cells nor any other lineages were found.”   In addition, differentiation in response to                 
              a particular lineage specific growth factor does not appear to exclude the presence of                         
              other lineages from the “multiple lineages of myeloid, lymphoid and erythroid cells” present                   
              in appellants’ graft.  See, e.g., Specification, page 13, Example 5.  If the term “having” is                  
              interpreted as open language the presence of other lineages can be included and bone                           
              marrow may meet the limitations of the claim.  Therefore, the scope of appellants’ claim                       


                                                             15                                                              








Page:  Previous  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  Next 

Last modified: November 3, 2007